Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer |
journalArticle |
2019 |
Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N. |
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy |
journalArticle |
2015 |
Blanchard, P.; Bakkour, M.; De Crevoisier, R.; Levy, A.; Baumert, H.; Patard, J. J.; Wibault, P.; Fizazi, K.; Bossi, A. |
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer |
journalArticle |
2016 |
Chemama, S.; Bayar, M. A.; Lanoy, E.; Ammari, S.; Stoclin, A.; Goere, D.; Elias, D.; Raynard, B.; Antoun, S. |
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial |
journalArticle |
2016 |
Ribrag, V.; Koscielny, S.; Bosq, J.; Leguay, T.; Casasnovas, O.; Fornecker, L. M.; Recher, C.; Ghesquieres, H.; Morschhauser, F.; Girault, S.; Le Gouill, S.; Ojeda-Uribe, M.; Mariette, C.; Cornillon, J.; Cartron, G.; Verge, V.; Chassagne-Clement, C.; Dombret, H.; Coiffier, B.; Lamy, T.; Tilly, H.; Salles, G. |
Preface |
journalArticle |
2016 |
Heinze, G.; Michiels, S.; Posch, M. |
Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer |
journalArticle |
2016 |
Ignatiadis, M.; Zardavas, D.; Lemort, M.; Wilke, C.; Vanderbeeken, M. C.; D'Hondt, V.; De Azambuja, E.; Gombos, A.; Lebrun, F.; Dal Lago, L.; Bustin, F.; Maetens, M.; Ameye, L.; Veys, I.; Michiels, S.; Paesmans, M.; Larsimont, D.; Sotiriou, C.; Nogaret, J. M.; Piccart, M.; Awada, A. |
Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best? |
journalArticle |
2016 |
Castelnau-Marchand, P.; Levy, A.; Moya-Plana, A.; Mirghani, H.; Nguyen, F.; Del Campo, E. R.; Janot, F.; Kolb, F.; Ferrand, F. R.; Temam, S.; Blanchard, P.; Tao, Y. |
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block? |
journalArticle |
2016 |
Ducreux, M.; Pignon, J. P. |
Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose |
journalArticle |
2018 |
Ezzalfani, Monia; Burzykowski, Tomasz; Paoletti, Xavier |
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials |
journalArticle |
2016 |
Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I. |
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure |
journalArticle |
2015 |
M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L. |
[A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial] |
journalArticle |
2017 |
Blanchard, P.; Foulon, S.; Louvel, G.; Habibian, M.; Fizazi, K. |
Nail toxicities induced by systemic anticancer treatments |
journalArticle |
2015 |
Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R. |
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial |
journalArticle |
2016 |
Ribrag, V.; Koscielny, S.; Bosq, J.; Leguay, T.; Casasnovas, O.; Fornecker, L. M.; Recher, C.; Ghesquieres, H.; Morschhauser, F.; Girault, S.; Le Gouill, S.; Ojeda-Uribe, M.; Mariette, C.; Cornillon, J.; Cartron, G.; Verge, V.; Chassagne-Clement, C.; Dombret, H.; Coiffier, B.; Lamy, T.; Tilly, H.; Salles, G. |
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research |
journalArticle |
2016 |
Blanchard, P.; Garden, A. S. |
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] |
journalArticle |
2019 |
Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
Statistical approaches for evaluating body composition markers in clinical cancer research |
journalArticle |
2017 |
Bayar, M. A.; Antoun, S.; Lanoy, E. |
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer |
journalArticle |
2018 |
Devarakonda, S.; Rotolo, F.; Tsao, M. S.; Lanc, I.; Brambilla, E.; Masood, A.; Olaussen, K. A.; Fulton, R.; Sakashita, S.; McLeer-Florin, A.; Ding, K.; Le Teuff, G.; Shepherd, F. A.; Pignon, J. P.; Graziano, S. L.; Kratzke, R.; Soria, J. C.; Seymour, L.; Govindan, R.; Michiels, S. |
Intramuscular administration of alfaxalone for sedation in rabbits |
journalArticle |
2015 |
Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L. |
Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics |
journalArticle |
2016 |
Rococo, E.; Mazouni, C.; Or, Z.; Mobillion, V.; Koon Sun Pat, M.; Bonastre, J. |
Multivariate joint frailty model for the analysis of nonlinear tumor kinetics and dynamic predictions of death |
journalArticle |
2018 |
Krol, A.; Tournigand, C.; Michiels, S.; Rondeau, V. |
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up |
journalArticle |
2015 |
Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S. |
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer |
journalArticle |
2019 |
Le Rhun, E.; Wallet, J.; Mailliez, A.; Le Deley, M. C.; Rodrigues, I.; Boulanger, T.; Lorgis, V.; Barriere, J.; Robin, Y. M.; Weller, M.; Bonneterre, J. |
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma |
journalArticle |
2019 |
Du, C.; Blanchard, P.; Even, C.; Boros, A.; Gorphe, P.; Breuskin, I.; Baste-Rotllan, N.; Nguyen, F.; Ruffier, A.; Bidault, F.; Billard, C.; Janot, F.; Mirghani, H.; Temam, S.; Tao, Y. |
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians |
journalArticle |
2015 |
Billaux, M.; Borget, I.; Prognon, P.; Pineau, J.; Martelli, N. |
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study |
journalArticle |
2016 |
Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C. |
[Network meta-analyses: Interest and limits in oncology] |
journalArticle |
2016 |
Ribassin-Majed, L.; Pignon, J. P.; Michiels, S.; Blanchard, P. |
Anatomic Variability of the Upper Mediastinal Lymph Node Level VII |
journalArticle |
2016 |
Hartl, D. M.; Breuskin, I.; Mirghani, H.; Berdelou, A.; Deandreis, D.; Pottier, E.; Borget, I.; Schlumberger, M.; Leboulleux, S. |
Equal access to innovative therapies and precision cancer care |
journalArticle |
2016 |
Buzyn, A.; Blay, J. Y.; Hoog-Labouret, N.; Jimenez, M.; Nowak, F.; Deley, M. C.; Perol, D.; Cailliot, C.; Raynaud, J.; Vassal, G. |
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence |
journalArticle |
2016 |
Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C. |
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials |
journalArticle |
2016 |
Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T. |
Innovations for phase I dose-finding designs in pediatric oncology clinical trials |
journalArticle |
2016 |
Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X. |
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates |
journalArticle |
2018 |
Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C. |
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma |
journalArticle |
2017 |
Bacorro, W.; Escande, A.; Temam, S.; Dumas, I.; Routier, E.; Gensse, M. C.; Blanchard, P.; Janot, F.; Mateus, C.; Tao, Y.; Robert, C.; Deutsch, E.; Haie-Meder, C.; Chargari, C. |
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab |
journalArticle |
2016 |
Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S. |
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France |
journalArticle |
2021 |
Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J |
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort |
journalArticle |
2017 |
Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A. |
Designs of drug-combination phase I trials in oncology: a systematic review of the literature |
journalArticle |
2015 |
Riviere, M. K.; Le Tourneau, C.; Paoletti, X.; Dubois, F.; Zohar, S. |